AMCP sends letter to the House Judiciary Subcommittee on Commercial & Antitrust Law in support of H.R. 2212, the CREATES Act, bipartisan legislation designed to increase patient access to generic and biosimilar medications.
AMCP sends letter to the House Judiciary Subcommittee on Commercial & Antitrust Law in support of H.R. 2212, the CREATES Act, bipartisan legislation designed to increase patient access to generic and biosimilar medications.